Studies have also suggested that miR-185 can downregulate the activity and function of RhoA and Cdc42 by targeting sites in the RhoA and Cdc42 3’UTR, which then can suppress the proliferation and invasiveness of the colorectal cancer cells [115]. This evidence concerns the gene CDC42 and colorectal cancer.